MS Nurse Resources
Biogen has developed and funded a range of services to support multiple sclerosis (MS) nurses in their management of people with MS, as well as directly supporting patients with patient support programmes. Resources such as progressive multifocal leukocephalopathy (PML) management support, an infusion nurse service and motivational interviewing skills training. These services have been developed to assist MS nurse practice and ensure the correct monitoring of patients on disease-modifying treatments (DMTs) is optimised for both safety and efficacy. Biogen’s patient support programmesalso provide educational information to patients with regards to their treatment.
Biogen offers Clinical Homecare Services to MS patients who are being treated with Avonex, Plegridy, Fampyra and Tecfidera. This service enhances the overall healthcare service offering to patients including greater patient choice of care delivery at a time and place which is convenient to them; at home, work or at a UK holiday location. Proactive prescription management and regular contact with patients reduce risk of missed doses and improves adherence to treatment.
Biogen work closely with four homecare providers to offer choice of service provider and ensure high quality clinical homecare services which are secure, fully traceable with a temperature-assured supply chain with full UK coverage. Biogen invest dedicated resource to assure the quality of clinical homecare service provided and ensure the service continues to meet the needs of patients and healthcare professionals. The homecare providers include Alcura, Healthcare at Home, HealthNet and Lloyds Pharmacy Clinical Homecare.
Non-Medical Prescribing Educational Update Meeting
Annual CPD accredited meeting providing essential clinical and medicolegal updates to support symptomatic and disease modifying prescribing, with plenaries and interactive workshops. Specifically designed for Non-medical prescribers in MS, e.g. specialist nurses or pharmacists with the non-medical prescribing qualification, who are in training as well as those considering taking the qualification to prescribe.
Northern Update Meeting
CPD accredited multi-disciplinary meeting providing updates on new DMT data and NHS initiatives, and interactive service and patient-outcome related workshops. The meeting is tailored for multidisciplinary teams working in MS, in particular neurologists, specialist nurses and neurology pharmacists
Motivational interviewing (MI) is a patient-centred, directive method for enhancing intrinsic motivation to change. It is a powerful tool for nurses to support behaviour change in patients.
Biogen is providing motivational interviewing skills training to MS and neurology nurses in the UK & Ireland. The learning objectives are for participants to:
Identify how MI can be used as a tool to support behaviour change in people with MS
Discover how to apply the principles of MI to improve the well-being of people with MS
Describe the elements of four key MI techniques
Gain direct experience of using an MI approach during skills-practice sessions.
The programme has been developed in consultation with nurses and is designed to facilitate on- going, peer-to-peer support.
PML can be a risk factor with some DMTs and dealing with a suspected case in an MS patient can be a complicated and difficult process for Healthcare Professionals. To meet this need, Biogen has developed a comprehensive electronic resource pack which provides Healthcare Professionals with information that will help to assist with reporting, investigating and managing suspected case of PML. To receive a copy of a resource pack for the identification and management of suspected PML cases in patients treated with DMTs, speak to your local Biogen representative, or email using the button below, for more information.
Patient Support Programmes
Biogen’s patient support programmes provide educational information to patients with regards to their treatment. Support programmes are in place for Avonex® (interferon beta-1a), Plegridy® (peginterferon beta-1a), Tecfidera® (dimethyl fumarate) and Tysabri®▼ (natalizumab) (UK Only). Enrollment of a patient into a support programme can only occur after the prescribing decision has been made.
The Avonex and Plegridy Patient Support Programme provides at-home injection training and phone support to patients for their prescribed injectable therapy.
The Tecfidera Support Line is a nurse-led telephone line that provides patients prescribed Tecfidera with educational assistance and support.
The Tysabri Infusion Nurse Service is aimed at NHS HCPs to support patients prescribed Tysabri with the administration of Tysabri.
Biogen-10874 Date of prep: May 2019